Lucas de Breed, PhD, MBA
Lucas de Breed is a Director at INKEF Capital. He had 10 years of international experience in all phases of drug development. In his previous role at Deallus Consulting, he was responsible for the oncology business, and founded and managed the firm’s New York office. He has advised half a dozen early-stage therapeutics/medtech companies in both New York and San Francisco.
Lucas holds a Ph.D. from University College London and an MBA from Stanford University. He has also co-authored several scientific papers.